🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
2 different formulations and 4 different single doses of tafamidis will be ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2018-09-28
Trial ID
NCT03662191
Treatments Being Tested
3 different formulations and doses of tafamidis will be compared. Subjects ...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-04
Trial ID
NCT02697864
Treatments Being Tested
This study is designed to determine the long-term safety and tolerability o...
Status
Completed
Location
FLENI Departamento de Hepatología y Transplante de Organos
Start Date
2008-07
Trial ID
NCT00791492
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Tafamid...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2025-06-19
Trial ID
NCT06940336
Treatments Being Tested
2 different formulations of tafamidis will be compared under both fed and f...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2017-09-29
Trial ID
NCT03280173
Treatments Being Tested
Open-label, multicenter, international, single-treatment study designed to ...
Status
Completed
Location
Emory University School of Medicine
Start Date
2008-08
Trial ID
NCT00694161
Treatments Being Tested
This is a 2 part study. In part 1 of the study, 3 different formulations of...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-09
Trial ID
NCT02534740
This Phase 3 study will investigate the efficacy, safety and tolerability o...
Status
Completed
Location
The Kirklin Clinic
Start Date
2013-12-09
Trial ID
NCT01994889
Study to characterize the bioequivalence of a 12.2 mg free acid tablets com...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2020-09-17
Trial ID
NCT04575116
Treatments Being Tested
All subjects in this study will be given tafamidis. After swallowing a sing...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-05
Trial ID
NCT02189330